FY22 - APA buildings - building 1
Active Awarded Last action
- Contract number
- 75N91022F00027
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,729,256
Award facts
- Contract value 100% obligated
- $5,729,256.00 Current and potential, with all options
- Completion date 93% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$190,881 | |
| Terminate for Convenience | $0 | |
| Supplemental Agreement for work within scope | $470,914 | |
| Other Administrative Action | $0 | |
| Original award | $5,449,223 |
About this award
The National Cancer Institute awarded a $5.73 million cost-plus-fixed-fee delivery order contract to Leidos Biomedical Research Inc. for FY22 APA Buildings - Building 1 work in Frederick, Maryland, with an ultimate completion date of February 5, 2027. Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., operates as a Federally Funded Research and Development Center contractor specializing in comprehensive biomedical research and facilities support services. This delivery order, which was not designated as a set-aside contract, represents task work under a larger indefinite delivery vehicle and focuses on building-related improvements and support for the Frederick National Laboratory for Cancer Research operations.
As an FFRDC contractor to the National Cancer Institute and National Institutes of Health, Leidos Biomedical Research Inc. delivers critical research infrastructure, facility management, and operational support essential to the agency's cancer research mission. The contractor's extensive experience in biomedical research support, clinical trials coordination, laboratory operations, and specialized scientific services positions it to execute the building improvements and facilities work required under this delivery order. The cost-plus-fixed-fee structure allows for flexibility in managing the scope of work while maintaining cost controls through the fixed-fee component, which is typical for federally funded research center operations supporting complex scientific missions.
Quick answers
Who was awarded contract 75N91022F00027?
75N91022F00027 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 20, 2022.
How much is contract 75N91022F00027 worth?
The government has obligated $5,729,256 on 75N91022F00027.
Is contract 75N91022F00027 an order under another contract?
Yes. 75N91022F00027 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91022F00027 competed?
The extent of competition for 75N91022F00027 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award